Johnson & Johnson Q3 FY2025 Earnings Call

Johnson & Johnson (JNJ)

Earnings Call FY2025 Q3 Call date: 2025-01-22 Concluded

Quarter scorecard

Revenue

$22.47B

+5.2% YoY

Diluted EPS

$1.11

-89.1% YoY

Gross margin

69.0%

-0.1 pp YoY

Net income

$2.69B

-89.6% YoY

Innovative Medicine $14.58B

+4.9%

MedTech $7.89B

+5.8%

Buybacks (derived)

$539.00M

Dividend / share

$1.24

ex Feb 18